Olvi Oyj (LON:0FHS)
31.15
+0.20 (0.65%)
At close: Dec 18, 2025
Olvi Oyj Revenue
Olvi Oyj had revenue of 186.21M EUR in the quarter ending September 30, 2025, with 0.70% growth. This brings the company's revenue in the last twelve months to 661.03M, up 2.54% year-over-year. In the year 2024, Olvi Oyj had annual revenue of 656.91M with 4.17% growth.
Revenue (ttm)
661.03M EUR
Revenue Growth
+2.54%
P/S Ratio
0.97
Revenue / Employee
274.97K EUR
Employees
2,404
Market Cap
561.47M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 656.91M | 26.30M | 4.17% |
| Dec 31, 2023 | 630.61M | 46.90M | 8.04% |
| Dec 31, 2022 | 583.70M | 121.48M | 26.28% |
| Dec 31, 2021 | 462.23M | 47.34M | 11.41% |
| Dec 31, 2020 | 414.88M | 6.18M | 1.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |